YZC-10802-60380
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 107 / NY
- Registered
- 2021-07-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-30
Registered in v-safe
-
2021-07-30
Dose 1 — Pfizer-BioNTech
- 2021-07-30
-
2021-07-31
Survey response — days 1–6 daily, dose 1MedDRA: Breast feeding, Galactostasis — Feeling: GoodFree text: Blocked breast ducts (breastfeeding)MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-01
- 2021-08-02
- 2021-08-04
- 2021-08-05
- 2021-08-06
- 2021-08-15
- 2021-08-20
-
2021-08-24
Dose 2 — Pfizer-BioNTech
- 2021-09-03
- 2021-09-07
- 2021-09-16
- 2021-09-21
- 2021-09-30
- 2021-10-05
-
2021-11-23
Survey response — 3 months, dose 2MedDRA: Pelvic organ prolapse, Postpartum state — Feeling: Good · Be unable to do your normal daily activitiesFree text: Organ prolapse 4 months postpartumMedDRA releases: 2024-11 · check-in free text available
- 2022-02-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-30 | Pfizer-BioNTech | No |
| 2 | 2021-08-24 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Blocked breast ducts (breastfeeding)
Release 10 — 3 months, dose 2
Symptoms: Organ prolapse 4 months postpartum
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pelvic organ prolapse | · | · | ✓ |
| SD | Postpartum state | · | · | ✓ |
| SRO | Breast feeding | ✓ | · | ✓ |
| SRO | Galactostasis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release